- Home
- THRD vs LE Comparison
THRD vs LE Comparison
Compare THRD & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- LE
- Stock Information
- Founded
- THRD 2019
- LE 1963
- Country
- THRD United States
- LE United States
- Employees
- THRD N/A
- LE N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- LE Clothing/Shoe/Accessory Stores
- Sector
- THRD Health Care
- LE Consumer Discretionary
- Exchange
- THRD Nasdaq
- LE Nasdaq
- Market Cap
- THRD 238.7M
- LE 280.4M
- IPO Year
- THRD 2022
- LE N/A
- Fundamental
- Price
- THRD $5.42
- LE $10.54
- Analyst Decision
- THRD Hold
- LE Strong Buy
- Analyst Count
- THRD 3
- LE 1
- Target Price
- THRD $5.00
- LE $20.00
- AVG Volume (30 Days)
- THRD 251.2K
- LE 682.5K
- Earning Date
- THRD 08-07-2025
- LE 06-05-2025
- Dividend Yield
- THRD N/A
- LE N/A
- EPS Growth
- THRD N/A
- LE N/A
- EPS
- THRD N/A
- LE 0.14
- Revenue
- THRD N/A
- LE $1,338,672,000.00
- Revenue This Year
- THRD N/A
- LE $3.31
- Revenue Next Year
- THRD N/A
- LE $2.34
- P/E Ratio
- THRD N/A
- LE $77.51
- Revenue Growth
- THRD N/A
- LE N/A
- 52 Week Low
- THRD $3.18
- LE $7.65
- 52 Week High
- THRD $16.02
- LE $19.88
- Technical
- Relative Strength Index (RSI)
- THRD 68.70
- LE 63.70
- Support Level
- THRD $5.41
- LE $8.98
- Resistance Level
- THRD $5.52
- LE $9.76
- Average True Range (ATR)
- THRD 0.05
- LE 0.87
- MACD
- THRD -0.01
- LE 0.19
- Stochastic Oscillator
- THRD 64.29
- LE 97.97
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.